Compare INUV & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INUV | BDSX |
|---|---|---|
| Founded | N/A | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Advertising | Precision Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 52.5M | 62.5M |
| IPO Year | N/A | 2020 |
| Metric | INUV | BDSX |
|---|---|---|
| Price | $2.56 | $6.65 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | $14.00 | ★ $32.50 |
| AVG Volume (30 Days) | ★ 105.1K | 66.8K |
| Earning Date | 11-06-2025 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $98,139,861.00 | $80,173,000.00 |
| Revenue This Year | $20.86 | $20.75 |
| Revenue Next Year | $14.59 | $25.05 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 25.11 | 22.29 |
| 52 Week Low | $2.34 | $3.44 |
| 52 Week High | $7.90 | $31.20 |
| Indicator | INUV | BDSX |
|---|---|---|
| Relative Strength Index (RSI) | 40.88 | 41.71 |
| Support Level | $2.50 | $6.56 |
| Resistance Level | $2.77 | $7.03 |
| Average True Range (ATR) | 0.17 | 0.59 |
| MACD | -0.02 | -0.15 |
| Stochastic Oscillator | 11.65 | 22.12 |
Inuvo Inc develops and sells information technology solutions for marketing. It develops technology to deliver content and targeted advertisements over the internet. Its products and services include ValidClick and IntentKey. The company's platforms identify and message online audiences for any product or service across devices, channels, and formats, including video, mobile, connected TV, display, social, and native. It has clients from various industries that include retail, automotive, insurance, health care, technology, telecommunications and finance. Inuvo's revenue is derived from the placement of digital advertising throughout devices, websites, applications and browsers across social, search and programmatic advertising channels.
Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.